PPH icon

VanEck Pharmaceutical ETF
PPH

Overview Fund Trends Analyst Outlook Journalist POV

51 hedge funds and large institutions have $98.3M invested in VanEck Pharmaceutical ETF in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

45% less capital invested

Capital invested by funds: $177M → $98.3M (-$79.2M)

Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$13.1M
2
+$4.78M
3
+$4.13M
4
CC
Colrain Capital
Massachusetts
+$2.4M
5
Morgan Stanley
Morgan Stanley
New York
+$1.43M

Top Sellers

1
-$65.6M
2
-$15.8M
3
-$3.7M
4
VF
Virtu Financial
New York
-$2.32M
5
AL
Aspiriant LLC
California
-$1.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
51
–
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
1 2
3